Response to Drs. Bell and Moore commentary regarding the use of intravenous ketamine for CRPS.
Schwartzman
Robert J
RJ
Department of Neurology, Drexel University College of Medicine, 245 N. 15th Street, Mail Stop 423, Room 7102, Philadelphia, PA 19102-1192, USA.
D000700:Analgesics / Q000008:administration & dosage*; D020918:Complex Regional Pain Syndromes / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007275:Injections, Intravenous / Q000379:methods; D007649:Ketamine / Q000008:administration & dosage*
D000700:Analgesics; D007649:Ketamine
Bell RF, Moore RA. Intravenous ketamine for CRPS: making too much of too little? Pain. 2010;150:10-11.
Curran HV, Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction. 2001;96:749-760.
Kiefer RT, Rohr P, Ploppa A, Dieterich HJ, Grothusen J, Koffler S, Altemeyer KH, Unertl K, Schwartzman RJ. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med. 2008;9:1173-1201.
Koffler SP, Hampstead BM, Irani F, Tinker J, Kiefer RT, Rohr P, Schwartzman RJ. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol. 2007;22:719-729.
Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang DR, Khenissi L, Cooper TB, Laruelle M, Abi-Dargham A. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry. 2005;162:2352-2359.
Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009;147:107-115.